Science and technology in Israel, CNX Nifty, Petah Tikva
View larger

Science and technology in Israel, CNX Nifty, Petah Tikva

580751

  • High School
  • 1092

Short excerpt:

1. It is evident from the case analysis that innovative product lines are the most potential resources/capabilities of the Teva Pharmaceuticals Industries Ltd according to VRINE criteria. Teva entered innovative drug market in the early 1980s and the company‰Ђ™s strong relationship with Israeli academic institutions added value to its wider market expansion. They jointly developed and launched three drugs including their blockbuster drug Copaxone which became an effective treatment for multiple sclerosis. The company‰Ђ™s drug Copaxone attained a ‰Ђrare status‰Ђ™, since there had been no other effective treatment for this disease. As the company extremely relied on external institutions for drug discovery, they could develop highly effective drugs at relatively lower costs. Therefore, it

Protected by Copyscape

By buying this product you can collect up to 43 loyalty points. Your cart will total 43 loyalty points that can be converted into a voucher of $0.43.


$4.37

Add to wishlist


30 other papers in the same category:

Related Products